Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,899 | 482 | 99.7% |
| Education | $21.33 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,753 | 125 | $0 (2024) |
| Novo Nordisk Inc | $1,123 | 64 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,030 | 61 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $580.90 | 40 | $0 (2021) |
| ABBVIE INC. | $504.76 | 31 | $0 (2024) |
| Amgen Inc. | $467.86 | 23 | $0 (2024) |
| Lilly USA, LLC | $420.41 | 21 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $317.34 | 15 | $0 (2022) |
| Allergan, Inc. | $283.34 | 18 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $194.46 | 18 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $253.36 | 9 | Phathom Pharmaceuticals, Inc. ($136.29) |
| 2023 | $402.69 | 15 | IDORSIA PHARMACEUTICALS US INC ($88.69) |
| 2022 | $335.08 | 19 | Novo Nordisk Inc ($82.55) |
| 2021 | $867.60 | 50 | PFIZER INC. ($197.13) |
| 2020 | $1,096 | 66 | PFIZER INC. ($337.16) |
| 2019 | $1,100 | 77 | PFIZER INC. ($229.80) |
| 2018 | $1,495 | 100 | PFIZER INC. ($496.20) |
| 2017 | $2,370 | 149 | Boehringer Ingelheim Pharmaceuticals, Inc. ($464.62) |
All Payment Transactions
485 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $120.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Inflammation | ||||||
| 05/07/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.96 | General |
| Category: Cardiovascular | ||||||
| 04/22/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.75 | General |
| 03/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/19/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: IMMUNOLOGY | ||||||
| 02/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.43 | General |
| 02/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Cardiology | ||||||
| 11/14/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.63 | General |
| 10/19/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $85.15 | General |
| Category: Diabetes | ||||||
| 10/09/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/19/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.83 | General |
| 08/25/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Cardiology | ||||||
| 08/03/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: VACCINES | ||||||
| 07/18/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/10/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 06/14/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.52 | General |
| 06/08/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $88.69 | General |
| Category: INSOMNIA | ||||||
| 03/18/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.67 | General |
| 03/01/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: NEUROSCIENCE | ||||||
| 01/20/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.58 | General |
| 11/12/2022 | PFIZER INC. | ELIQUIS (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 969 | 1,876 | $172,343 | $92,478 |
| 2022 | 9 | 1,066 | 2,037 | $181,075 | $95,676 |
| 2021 | 9 | 1,216 | 2,298 | $209,278 | $116,302 |
| 2020 | 8 | 1,015 | 2,058 | $171,939 | $88,134 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 301 | 880 | $77,740 | $45,027 | 57.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 307 | 528 | $68,655 | $36,360 | 53.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 69 | 71 | $10,788 | $5,363 | 49.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 86 | 86 | $6,622 | $1,790 | 27.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 64 | 64 | $1,344 | $1,317 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 70 | 150 | $3,150 | $1,283 | 40.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 19 | 27 | $1,944 | $944.75 | 48.6% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 38 | 45 | $1,800 | $312.20 | 17.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 15 | 25 | $300.00 | $80.25 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 325 | 952 | $83,843 | $47,762 | 57.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 325 | 536 | $69,680 | $34,625 | 49.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 84 | 87 | $13,183 | $7,080 | 53.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 97 | 97 | $2,658 | $2,435 | 91.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 101 | 101 | $5,555 | $2,023 | 36.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 61 | 151 | $3,180 | $1,277 | 40.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 42 | 47 | $1,880 | $339.69 | 18.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 20 | 28 | $336.00 | $90.59 | 27.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 11 | 38 | $760.00 | $44.06 | 5.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 367 | 1,073 | $93,831 | $55,828 | 59.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 363 | 633 | $81,467 | $43,217 | 53.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 121 | 125 | $18,913 | $11,230 | 59.4% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 114 | 115 | $6,325 | $2,243 | 35.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 85 | 164 | $3,444 | $1,376 | 40.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 78 | 78 | $1,638 | $1,218 | 74.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 21 | 26 | $1,872 | $975.78 | 52.1% |
About Dr. Kenneth Cook, MD
Dr. Kenneth Cook, MD is a Family Medicine healthcare provider based in Paducah, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720169501.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Cook, MD has received a total of $7,920 in payments from pharmaceutical and medical device companies, with $253.36 received in 2024. These payments were reported across 485 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($7,899).
As a Medicare-enrolled provider, Cook has provided services to 4,266 Medicare beneficiaries, totaling 8,269 services with total Medicare billing of $392,590. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Paducah, KY
- Active Since 10/18/2006
- Last Updated 12/22/2009
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1720169501
Products in Payments
- JARDIANCE (Drug) $686.18
- CHANTIX (Drug) $642.83
- ELIQUIS (Drug) $454.90
- Ozempic (Drug) $392.22
- LYRICA (Drug) $323.47
- Victoza (Drug) $279.32
- PRADAXA (Drug) $258.71
- FARXIGA (Drug) $250.68
- XARELTO (Drug) $237.97
- UBRELVY (Drug) $236.03
- Tresiba (Drug) $205.50
- Aimovig (Biological) $196.56
- Vascepa (Drug) $157.74
- SYMBICORT (Drug) $149.81
- Prolia (Biological) $149.70
- SYNTHROID (Drug) $140.87
- VOQUEZNA (Drug) $136.29
- BEVESPI AEROSPHERE (Drug) $114.41
- EUCRISA (Drug) $114.27
- Livalo (Drug) $104.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Paducah
James Turnbo, M.d. Psc, M.D. PSC
Family Medicine — Payments: $102,611
Dr. James Eickholz, Md, MD
Family Medicine — Payments: $15,716
Marissa Stewart-Jaynes, Md, MD
Family Medicine — Payments: $11,353
Mrs. Jennifer Nelson, Do, DO
Family Medicine — Payments: $9,999
Kyle Parish, Md, MD
Family Medicine — Payments: $9,910
Isaac Mittendorf, Md, MD
Family Medicine — Payments: $9,065